
Canaccord Genuity and Needham analysts initiate coverage of Omada Health Inc (NASDAQ:OMDA) with a Buy rating.
- Canaccord Genuity analyst Richard Close assigns a price target of $27.
- Needham analyst Ryan MacDonald assigns a price target of $23.

Canaccord Genuity and Needham analysts initiate coverage of Omada Health Inc (NASDAQ:OMDA) with a Buy rating.